UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036882
Receipt number R000042029
Scientific Title Clarification of gut microbiota in patients with esophageal cancer closely related to a life style.
Date of disclosure of the study information 2020/03/31
Last modified on 2020/05/07 11:41:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clarification of gut microbiota in patients with esophageal cancer closely related to a life style.

Acronym

Clarification of gut microbiota in patients with esophageal cancer.

Scientific Title

Clarification of gut microbiota in patients with esophageal cancer closely related to a life style.

Scientific Title:Acronym

Clarification of gut microbiota in patients with esophageal cancer.

Region

Japan


Condition

Condition

esophageal cancer

Classification by specialty

Gastroenterology Hepato-biliary-pancreatic medicine Gastrointestinal surgery
Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify of dysbiosis in patients with esophageal cancer closely related to a life style and investigate causal relationship between gut microbiota and preoperative chemoradiation therapy or surgery.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

The characteristics of gut microbiota in patient with esophageal cancer
The effect of chemoradiation therapy and surgery on gut microbiota in patient with esophageal cancer

Key secondary outcomes

Correlation with gut microbiota and surgical outcome, survival, clinical findings, blood biochemistry finding and presence of gastrointestinal symptoms


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) The patients who are diagnosed esophageal cancer and planned to be treated in Kyusyu University Hospital or Fukuoka Dental College Hospital
2) The person who understand the details of the study and have the ability to provide informed consent

Key exclusion criteria

1) The patients who are pregnant or may be pregnant
2) The patients with psychiatric disorders.
3) The patients who are judged that participation in the study is inadequate by the medical attendant

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Tomoharu
Middle name
Last name Yoshizumi

Organization

Graduate School of Medical Sciences, Kyushu University

Division name

Department of Surgery and Science

Zip code

812-8582

Address

3-1-1, Maidashi, Higashiku, Fukuoka city, Fukuoka, Japan

TEL

092-642-5462

Email

yosizumi@surg2.med.kyushu-u.ac.jp


Public contact

Name of contact person

1st name Hirofumi
Middle name
Last name Hasuda

Organization

Graduate School of Medical Sciences, Kyushu University

Division name

Department of Surgery and Science

Zip code

812-8582

Address

3-1-1, Maidashi, Higashiku, Fukuoka city, Fukuoka, Japan

TEL

092-642-5466

Homepage URL


Email

h-hasuda@surg2.med.kyushu-u.ac.jp


Sponsor or person

Institute

Kyushu University

Institute

Department

Personal name



Funding Source

Organization

Self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Fukuoka Dental College Hospital
Biofermin Pharmaceutical Co., Ltd.

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Kyushu University

Address

3-1-1, Maidashi, Higashiku, Fukuoka city, Fukuoka, Japan

Tel

092-642-5774

Email

ijkseimei@jimu.kyushu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 01 Month 28 Day

Date of IRB

2019 Year 01 Month 28 Day

Anticipated trial start date

2019 Year 01 Month 28 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

[Study design]
Prospective observational study

[Recruitment of target people]
During the experimental period, the person who are planned to be treated in Kyusyu University Hospital or Fukuoka Dental College Hospital, satisfy selection criteria and write informed consent to participate in this study.

[measurement item]
Gut microbiota


Management information

Registered date

2019 Year 05 Month 29 Day

Last modified on

2020 Year 05 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042029


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name